These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 648557)

  • 41. Nuclear binding as a determinant of tissue distribution of adriamycin, daunomycin, adriamycinol, daunorubicinol and actinomycin D.
    Terasaki T; Iga T; Sugiyama Y; Sawada Y; Hanano M
    J Pharmacobiodyn; 1984 May; 7(5):269-77. PubMed ID: 6470925
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cell cycle related uptake, retention and toxicity of idarubicin, daunorubicin and doxorubicin.
    Minderman H; Linssen P; Wessels J; Haanen C
    Anticancer Res; 1993; 13(4):1161-5. PubMed ID: 8352539
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adriamycin and daunorubicin bind in a cooperative manner to deoxyribonucleic acid.
    Graves DE; Krugh TR
    Biochemistry; 1983 Aug; 22(16):3941-7. PubMed ID: 6615810
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation of multidrug resistance with decreased drug accumulation, altered subcellular drug distribution, and increased P-glycoprotein expression in cultured SW-1573 human lung tumor cells.
    Keizer HG; Schuurhuis GJ; Broxterman HJ; Lankelma J; Schoonen WG; van Rijn J; Pinedo HM; Joenje H
    Cancer Res; 1989 Jun; 49(11):2988-93. PubMed ID: 2566376
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Doxorubicin and daunorubicin plasmatic, hepatic and renal disposition in the rabbit with or without enterohepatic circulation.
    Maniez-Devos DM; Baurain R; Lesne M; Trouet A
    J Pharmacol; 1986; 17(1):1-13. PubMed ID: 3713196
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interaction of aclarubicin with DNA as compared with daunorubicin and doxorubicin.
    Ando S; Sasada M; Uchino H; Kagawa D; Ueda T; Nakamura T
    Nihon Gan Chiryo Gakkai Shi; 1986 Dec; 21(10):2343-55. PubMed ID: 3471823
    [No Abstract]   [Full Text] [Related]  

  • 47. Proceedings: Daunomycin and adriamycin antitumor cell antibody conjugates.
    Hurwitz E; Levy R; Maron R
    Isr J Med Sci; 1975 Dec; 11(12):1396. PubMed ID: 1218993
    [No Abstract]   [Full Text] [Related]  

  • 48. Distribution of adriamycin in tissues & subcellular fractions.
    Muhammed H; Kurup CK
    Indian J Biochem Biophys; 1983 Dec; 20(6):349-52. PubMed ID: 6674119
    [No Abstract]   [Full Text] [Related]  

  • 49. Transferrin uptake by cultured rat embryo fibroblasts. The influence of lysosomotropic agents, iron chelators and colchicine on the uptake of iron and transferrin.
    Octave JN; Schneider YJ; Hoffmann P; Trouet A; Crichton RR
    Eur J Biochem; 1982 Apr; 123(2):235-40. PubMed ID: 7075588
    [No Abstract]   [Full Text] [Related]  

  • 50. Cellular uptake and subcellular distribution of two non-steroidal anti-inflammatory drugs: indomethacin and ketoprofen.
    Blanchard JC; Schneider YJ; Tulkens P; Trouet A
    Arch Int Pharmacodyn Ther; 1979 Jul; 240(1):4-16. PubMed ID: 507996
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetic, toxicologic, and chemotherapeutic properties of detorubicin in mice: a comparative study with daunorubicin and adriamycin.
    Deprez-de Campeneere D; Baurain R; Trouet A
    Cancer Treat Rep; 1979 May; 63(5):861-7. PubMed ID: 455327
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Measurements of daunorubicin uptake of Yoshida sarcoma cells in culture using flow cytofluorimetry.
    Garner A; Fox BW
    Chem Biol Interact; 1981 Aug; 36(2):189-210. PubMed ID: 7273243
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Body residue and metabolism of adriamycin and daunorubicin in control and phenobarbital-pretreated mice.
    Bolanowska W; Gessner T
    Xenobiotica; 1982 Feb; 12(2):125-36. PubMed ID: 7090422
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycin.
    Goodman J; Hochstein P
    Biochem Biophys Res Commun; 1977 Jul; 77(2):797-803. PubMed ID: 20093
    [No Abstract]   [Full Text] [Related]  

  • 55. Influence of S9788, a new modulator of multidrug resistance, on the cellular accumulation and subcellular distribution of daunorubicin in P-glycoprotein-expressing MCF7 human breast adenocarcinoma cells.
    Merlin JL; Marchal S; Ramacci C; Dieterlen A; Schultz G; Lucas C; Poullain MG; Berlion M
    Cytometry; 1995 Aug; 20(4):315-23. PubMed ID: 7587719
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.
    Inaba M; Kobayashi H; Sakurai Y; Johnson RK
    Cancer Res; 1979 Jun; 39(6 Pt 1):2200-3. PubMed ID: 445418
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distribution and metabolism of daunomycin, adriamycin, and N-acetyldaunomycin in the Syrian golden hamster.
    Mhatre RM; Herman EH; Waravdekar VS; Lee IP
    Biochem Med; 1972 Oct; 6(5):445-53. PubMed ID: 5075698
    [No Abstract]   [Full Text] [Related]  

  • 58. Comparison of methyltrienolone and dihydrotestosterone binding and metabolism in human genital skin fibroblasts.
    Brown TR; Rothwell SW; Migeon CJ
    J Steroid Biochem; 1981 Oct; 14(10):1013-22. PubMed ID: 6975397
    [No Abstract]   [Full Text] [Related]  

  • 59. Cytofluorescence localization of anthracycline antibiotics.
    Egorin MJ; Clawson RE; Cohen JL; Ross LA; Bachur NR
    Cancer Res; 1980 Dec; 40(12):4669-76. PubMed ID: 6934029
    [No Abstract]   [Full Text] [Related]  

  • 60. Another hypothesis concerning the antitumor activity and cardiotoxicity of daunorubicin (NSC-82151) and adriamycin (NSC-123127).
    Wheeler DM
    Cancer Chemother Rep; 1975; 59(2 Pt 1):258-9. PubMed ID: 1149002
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.